NSCLC-Erkrankte profitieren langfristig von Immun-Chemo-Kombination
Crossref DOI link: https://doi.org/10.1007/s15033-023-3475-7
Published Online: 2023-02-28
Published Print: 2023-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sonnet, Miriam
Text and Data Mining valid from 2023-02-28
Version of Record valid from 2023-02-28
Article History
First Online: 28 February 2023
Free to read: This content has been made available to all.